Vasopressin for Vasoplegic Shock Market, Global Outlook and Forecast 2022-2028

March 2022 | 63 pages | ID: VF8BCBA13D25EN
Market Monitor Global

Abstracts

Vasoplegia is a type of syndrome that involves pathologically low systemic vascular resistance. It further leads to reduced blood pressure amid presence of a raised cardiac output. Vasopressin is an antidiuretic hormone directed to be used for the treatment and prevention of postoperative abdominal distention in abdominal roentgenography. lt is mosty used as an intensive care medicine.Vasopressin infusion efficiently increases systemic vascular resistance and arterial pressure while improving survival chances in patients. Additionally, it decreases catecholamine vasopressors requirements in the patient with or at the risk of vasoplegic syndrome after cardiac surgery.

This report contains market size and forecasts of Vasopressin for Vasoplegic Shock in Global, including the following market information:

Global Vasopressin for Vasoplegic Shock Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Vasopressin for Vasoplegic Shock market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Intravenous Injection Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Vasopressin for Vasoplegic Shock include Endo International, AMOMED Pharma, La Jolla Pharmaceutical Company, Pfizer, Ferring Pharmaceuticals, Fresenius Kabi, Astellas Pharma and Eagle Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Vasopressin for Vasoplegic Shock companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Vasopressin for Vasoplegic Shock Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Vasopressin for Vasoplegic Shock Market Segment Percentages, by Type, 2021 (%)

• Intravenous Injection
• Intramuscular Injection
• Subcutaneous Injection

Global Vasopressin for Vasoplegic Shock Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Vasopressin for Vasoplegic Shock Market Segment Percentages, by Application, 2021 (%)

• Sepsis
• Post Cardiac Surgery
• Others

Global Vasopressin for Vasoplegic Shock Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Vasopressin for Vasoplegic Shock Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Vasopressin for Vasoplegic Shock revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Vasopressin for Vasoplegic Shock revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Endo International
• AMOMED Pharma
• La Jolla Pharmaceutical Company
• Pfizer
• Ferring Pharmaceuticals
• Fresenius Kabi
• Astellas Pharma
• Eagle Pharmaceuticals

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Vasopressin for Vasoplegic Shock Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Vasopressin for Vasoplegic Shock Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL VASOPRESSIN FOR VASOPLEGIC SHOCK OVERALL MARKET SIZE

2.1 Global Vasopressin for Vasoplegic Shock Market Size: 2021 VS 2028
2.2 Global Vasopressin for Vasoplegic Shock Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Vasopressin for Vasoplegic Shock Players in Global Market
3.2 Top Global Vasopressin for Vasoplegic Shock Companies Ranked by Revenue
3.3 Global Vasopressin for Vasoplegic Shock Revenue by Companies
3.4 Top 3 and Top 5 Vasopressin for Vasoplegic Shock Companies in Global Market, by Revenue in 2021
3.5 Global Companies Vasopressin for Vasoplegic Shock Product Type
3.6 Tier 1, Tier 2 and Tier 3 Vasopressin for Vasoplegic Shock Players in Global Market
  3.6.1 List of Global Tier 1 Vasopressin for Vasoplegic Shock Companies
  3.6.2 List of Global Tier 2 and Tier 3 Vasopressin for Vasoplegic Shock Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Vasopressin for Vasoplegic Shock Market Size Markets, 2021 & 2028
  4.1.2 Intravenous Injection
  4.1.3 Intramuscular Injection
  4.1.4 Subcutaneous Injection
4.2 By Type - Global Vasopressin for Vasoplegic Shock Revenue & Forecasts
  4.2.1 By Type - Global Vasopressin for Vasoplegic Shock Revenue, 2017-2022
  4.2.2 By Type - Global Vasopressin for Vasoplegic Shock Revenue, 2023-2028
  4.2.3 By Type - Global Vasopressin for Vasoplegic Shock Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Vasopressin for Vasoplegic Shock Market Size, 2021 & 2028
  5.1.2 Sepsis
  5.1.3 Post Cardiac Surgery
  5.1.4 Others
5.2 By Application - Global Vasopressin for Vasoplegic Shock Revenue & Forecasts
  5.2.1 By Application - Global Vasopressin for Vasoplegic Shock Revenue, 2017-2022
  5.2.2 By Application - Global Vasopressin for Vasoplegic Shock Revenue, 2023-2028
  5.2.3 By Application - Global Vasopressin for Vasoplegic Shock Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Vasopressin for Vasoplegic Shock Market Size, 2021 & 2028
6.2 By Region - Global Vasopressin for Vasoplegic Shock Revenue & Forecasts
  6.2.1 By Region - Global Vasopressin for Vasoplegic Shock Revenue, 2017-2022
  6.2.2 By Region - Global Vasopressin for Vasoplegic Shock Revenue, 2023-2028
  6.2.3 By Region - Global Vasopressin for Vasoplegic Shock Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Vasopressin for Vasoplegic Shock Revenue, 2017-2028
  6.3.2 US Vasopressin for Vasoplegic Shock Market Size, 2017-2028
  6.3.3 Canada Vasopressin for Vasoplegic Shock Market Size, 2017-2028
  6.3.4 Mexico Vasopressin for Vasoplegic Shock Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Vasopressin for Vasoplegic Shock Revenue, 2017-2028
  6.4.2 Germany Vasopressin for Vasoplegic Shock Market Size, 2017-2028
  6.4.3 France Vasopressin for Vasoplegic Shock Market Size, 2017-2028
  6.4.4 U.K. Vasopressin for Vasoplegic Shock Market Size, 2017-2028
  6.4.5 Italy Vasopressin for Vasoplegic Shock Market Size, 2017-2028
  6.4.6 Russia Vasopressin for Vasoplegic Shock Market Size, 2017-2028
  6.4.7 Nordic Countries Vasopressin for Vasoplegic Shock Market Size, 2017-2028
  6.4.8 Benelux Vasopressin for Vasoplegic Shock Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Vasopressin for Vasoplegic Shock Revenue, 2017-2028
  6.5.2 China Vasopressin for Vasoplegic Shock Market Size, 2017-2028
  6.5.3 Japan Vasopressin for Vasoplegic Shock Market Size, 2017-2028
  6.5.4 South Korea Vasopressin for Vasoplegic Shock Market Size, 2017-2028
  6.5.5 Southeast Asia Vasopressin for Vasoplegic Shock Market Size, 2017-2028
  6.5.6 India Vasopressin for Vasoplegic Shock Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Vasopressin for Vasoplegic Shock Revenue, 2017-2028
  6.6.2 Brazil Vasopressin for Vasoplegic Shock Market Size, 2017-2028
  6.6.3 Argentina Vasopressin for Vasoplegic Shock Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Vasopressin for Vasoplegic Shock Revenue, 2017-2028
  6.7.2 Turkey Vasopressin for Vasoplegic Shock Market Size, 2017-2028
  6.7.3 Israel Vasopressin for Vasoplegic Shock Market Size, 2017-2028
  6.7.4 Saudi Arabia Vasopressin for Vasoplegic Shock Market Size, 2017-2028
  6.7.5 UAE Vasopressin for Vasoplegic Shock Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Endo International
  7.1.1 Endo International Corporate Summary
  7.1.2 Endo International Business Overview
  7.1.3 Endo International Vasopressin for Vasoplegic Shock Major Product Offerings
  7.1.4 Endo International Vasopressin for Vasoplegic Shock Revenue in Global Market (2017-2022)
  7.1.5 Endo International Key News
7.2 AMOMED Pharma
  7.2.1 AMOMED Pharma Corporate Summary
  7.2.2 AMOMED Pharma Business Overview
  7.2.3 AMOMED Pharma Vasopressin for Vasoplegic Shock Major Product Offerings
  7.2.4 AMOMED Pharma Vasopressin for Vasoplegic Shock Revenue in Global Market (2017-2022)
  7.2.5 AMOMED Pharma Key News
7.3 La Jolla Pharmaceutical Company
  7.3.1 La Jolla Pharmaceutical Company Corporate Summary
  7.3.2 La Jolla Pharmaceutical Company Business Overview
  7.3.3 La Jolla Pharmaceutical Company Vasopressin for Vasoplegic Shock Major Product Offerings
  7.3.4 La Jolla Pharmaceutical Company Vasopressin for Vasoplegic Shock Revenue in Global Market (2017-2022)
  7.3.5 La Jolla Pharmaceutical Company Key News
7.4 Pfizer
  7.4.1 Pfizer Corporate Summary
  7.4.2 Pfizer Business Overview
  7.4.3 Pfizer Vasopressin for Vasoplegic Shock Major Product Offerings
  7.4.4 Pfizer Vasopressin for Vasoplegic Shock Revenue in Global Market (2017-2022)
  7.4.5 Pfizer Key News
7.5 Ferring Pharmaceuticals
  7.5.1 Ferring Pharmaceuticals Corporate Summary
  7.5.2 Ferring Pharmaceuticals Business Overview
  7.5.3 Ferring Pharmaceuticals Vasopressin for Vasoplegic Shock Major Product Offerings
  7.5.4 Ferring Pharmaceuticals Vasopressin for Vasoplegic Shock Revenue in Global Market (2017-2022)
  7.5.5 Ferring Pharmaceuticals Key News
7.6 Fresenius Kabi
  7.6.1 Fresenius Kabi Corporate Summary
  7.6.2 Fresenius Kabi Business Overview
  7.6.3 Fresenius Kabi Vasopressin for Vasoplegic Shock Major Product Offerings
  7.6.4 Fresenius Kabi Vasopressin for Vasoplegic Shock Revenue in Global Market (2017-2022)
  7.6.5 Fresenius Kabi Key News
7.7 Astellas Pharma
  7.7.1 Astellas Pharma Corporate Summary
  7.7.2 Astellas Pharma Business Overview
  7.7.3 Astellas Pharma Vasopressin for Vasoplegic Shock Major Product Offerings
  7.7.4 Astellas Pharma Vasopressin for Vasoplegic Shock Revenue in Global Market (2017-2022)
  7.7.5 Astellas Pharma Key News
7.8 Eagle Pharmaceuticals
  7.8.1 Eagle Pharmaceuticals Corporate Summary
  7.8.2 Eagle Pharmaceuticals Business Overview
  7.8.3 Eagle Pharmaceuticals Vasopressin for Vasoplegic Shock Major Product Offerings
  7.8.4 Eagle Pharmaceuticals Vasopressin for Vasoplegic Shock Revenue in Global Market (2017-2022)
  7.8.5 Eagle Pharmaceuticals Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Vasopressin for Vasoplegic Shock Market Opportunities & Trends in Global Market
Table 2. Vasopressin for Vasoplegic Shock Market Drivers in Global Market
Table 3. Vasopressin for Vasoplegic Shock Market Restraints in Global Market
Table 4. Key Players of Vasopressin for Vasoplegic Shock in Global Market
Table 5. Top Vasopressin for Vasoplegic Shock Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Vasopressin for Vasoplegic Shock Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Vasopressin for Vasoplegic Shock Revenue Share by Companies, 2017-2022
Table 8. Global Companies Vasopressin for Vasoplegic Shock Product Type
Table 9. List of Global Tier 1 Vasopressin for Vasoplegic Shock Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Vasopressin for Vasoplegic Shock Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Vasopressin for Vasoplegic Shock Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Vasopressin for Vasoplegic Shock Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Vasopressin for Vasoplegic Shock Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Vasopressin for Vasoplegic Shock Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Vasopressin for Vasoplegic Shock Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Vasopressin for Vasoplegic Shock Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Vasopressin for Vasoplegic Shock Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Vasopressin for Vasoplegic Shock Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Vasopressin for Vasoplegic Shock Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Vasopressin for Vasoplegic Shock Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Vasopressin for Vasoplegic Shock Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Vasopressin for Vasoplegic Shock Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Vasopressin for Vasoplegic Shock Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Vasopressin for Vasoplegic Shock Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Vasopressin for Vasoplegic Shock Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Vasopressin for Vasoplegic Shock Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Vasopressin for Vasoplegic Shock Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Vasopressin for Vasoplegic Shock Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Vasopressin for Vasoplegic Shock Revenue, (US$, Mn), 2023-2028
Table 30. Endo International Corporate Summary
Table 31. Endo International Vasopressin for Vasoplegic Shock Product Offerings
Table 32. Endo International Vasopressin for Vasoplegic Shock Revenue (US$, Mn), (2017-2022)
Table 33. AMOMED Pharma Corporate Summary
Table 34. AMOMED Pharma Vasopressin for Vasoplegic Shock Product Offerings
Table 35. AMOMED Pharma Vasopressin for Vasoplegic Shock Revenue (US$, Mn), (2017-2022)
Table 36. La Jolla Pharmaceutical Company Corporate Summary
Table 37. La Jolla Pharmaceutical Company Vasopressin for Vasoplegic Shock Product Offerings
Table 38. La Jolla Pharmaceutical Company Vasopressin for Vasoplegic Shock Revenue (US$, Mn), (2017-2022)
Table 39. Pfizer Corporate Summary
Table 40. Pfizer Vasopressin for Vasoplegic Shock Product Offerings
Table 41. Pfizer Vasopressin for Vasoplegic Shock Revenue (US$, Mn), (2017-2022)
Table 42. Ferring Pharmaceuticals Corporate Summary
Table 43. Ferring Pharmaceuticals Vasopressin for Vasoplegic Shock Product Offerings
Table 44. Ferring Pharmaceuticals Vasopressin for Vasoplegic Shock Revenue (US$, Mn), (2017-2022)
Table 45. Fresenius Kabi Corporate Summary
Table 46. Fresenius Kabi Vasopressin for Vasoplegic Shock Product Offerings
Table 47. Fresenius Kabi Vasopressin for Vasoplegic Shock Revenue (US$, Mn), (2017-2022)
Table 48. Astellas Pharma Corporate Summary
Table 49. Astellas Pharma Vasopressin for Vasoplegic Shock Product Offerings
Table 50. Astellas Pharma Vasopressin for Vasoplegic Shock Revenue (US$, Mn), (2017-2022)
Table 51. Eagle Pharmaceuticals Corporate Summary
Table 52. Eagle Pharmaceuticals Vasopressin for Vasoplegic Shock Product Offerings
Table 53. Eagle Pharmaceuticals Vasopressin for Vasoplegic Shock Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Vasopressin for Vasoplegic Shock Segment by Type in 2021
Figure 2. Vasopressin for Vasoplegic Shock Segment by Application in 2021
Figure 3. Global Vasopressin for Vasoplegic Shock Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Vasopressin for Vasoplegic Shock Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Vasopressin for Vasoplegic Shock Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Vasopressin for Vasoplegic Shock Revenue in 2021
Figure 8. By Type - Global Vasopressin for Vasoplegic Shock Revenue Market Share, 2017-2028
Figure 9. By Application - Global Vasopressin for Vasoplegic Shock Revenue Market Share, 2017-2028
Figure 10. By Region - Global Vasopressin for Vasoplegic Shock Revenue Market Share, 2017-2028
Figure 11. By Country - North America Vasopressin for Vasoplegic Shock Revenue Market Share, 2017-2028
Figure 12. US Vasopressin for Vasoplegic Shock Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Vasopressin for Vasoplegic Shock Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Vasopressin for Vasoplegic Shock Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Vasopressin for Vasoplegic Shock Revenue Market Share, 2017-2028
Figure 16. Germany Vasopressin for Vasoplegic Shock Revenue, (US$, Mn), 2017-2028
Figure 17. France Vasopressin for Vasoplegic Shock Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Vasopressin for Vasoplegic Shock Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Vasopressin for Vasoplegic Shock Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Vasopressin for Vasoplegic Shock Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Vasopressin for Vasoplegic Shock Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Vasopressin for Vasoplegic Shock Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Vasopressin for Vasoplegic Shock Revenue Market Share, 2017-2028
Figure 24. China Vasopressin for Vasoplegic Shock Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Vasopressin for Vasoplegic Shock Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Vasopressin for Vasoplegic Shock Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Vasopressin for Vasoplegic Shock Revenue, (US$, Mn), 2017-2028
Figure 28. India Vasopressin for Vasoplegic Shock Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Vasopressin for Vasoplegic Shock Revenue Market Share, 2017-2028
Figure 30. Brazil Vasopressin for Vasoplegic Shock Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Vasopressin for Vasoplegic Shock Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Vasopressin for Vasoplegic Shock Revenue Market Share, 2017-2028
Figure 33. Turkey Vasopressin for Vasoplegic Shock Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Vasopressin for Vasoplegic Shock Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Vasopressin for Vasoplegic Shock Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Vasopressin for Vasoplegic Shock Revenue, (US$, Mn), 2017-2028
Figure 37. Endo International Vasopressin for Vasoplegic Shock Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. AMOMED Pharma Vasopressin for Vasoplegic Shock Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. La Jolla Pharmaceutical Company Vasopressin for Vasoplegic Shock Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Pfizer Vasopressin for Vasoplegic Shock Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Ferring Pharmaceuticals Vasopressin for Vasoplegic Shock Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Fresenius Kabi Vasopressin for Vasoplegic Shock Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Astellas Pharma Vasopressin for Vasoplegic Shock Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Eagle Pharmaceuticals Vasopressin for Vasoplegic Shock Revenue Year Over Year Growth (US$, Mn) & (2017-2022)